Skip to main content
See every side of every news story
Published loading...Updated

Data Support First Approved Treatment for Acute Hepatitis C

Summary by MedPage Today
(MedPage Today) -- The direct-acting antiviral glecaprevir/pibrentasvir (Mavyret) was highly effective and well tolerated in adults with acute hepatitis C virus (HCV) infection, according to results from a multicenter phase IIIb trial. Among 286...

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Anti-Aging, Acupuncture and Health News broke the news in on Wednesday, November 26, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal